Moreover, importantly, combination of RGD4C.TPA.TNFα with CDDP resulted in further antitumor effects and reduction in tumor size and tumor viability, when compared to RGD4C.TPA‐TNFα‐ or CDDP‐treated groups (Figure 7A,B). This evidence concerns the gene TNF and neoplasm.